DarioHealth (DRIO) Cost of Revenue (2014 - 2026)

DarioHealth (DRIO) has 13 years of Cost of Revenue data on file, last reported at $2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 16.93% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $9.2 million (down 30.86% YoY), and the FY2025 full-year result was $9.7 million, down 29.62% from the prior year.
• Cost of Revenue for Q1 2026 stood at $2.4 million, down from $2.4 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $5.0 million in Q2 2022 and bottomed at $2.0 million in Q3 2025.
• The 5-year median for Cost of Revenue is $3.5 million (2023), against an average of $3.4 million.
• The widest annual swing landed in 2022, when Cost of Revenue surged 104.93%; it then sank 43.82% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $4.1 million in 2022, then fell by 14.55% to $3.5 million in 2023, then retreated by 2.35% to $3.4 million in 2024, then fell by 28.66% to $2.4 million in 2025, then fell by 1.77% to $2.4 million in 2026.
• The last three Cost of Revenue figures came in at $2.4 million (Q1 2026), $2.4 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison